We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Expert: Adaptive Design Useful for Dose-Ranging Studies
Expert: Adaptive Design Useful for Dose-Ranging Studies
November 11, 2009
With half of the drugs in Phase III programs never reaching the market, adaptive trial designs can help sponsors pinpoint Phase III dosages and increase clinical trial success, an expert says.